Why it was recalled
Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant product
Product description
Fougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & Co., a division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-15
Lot numbers, UPCs & expiration codes
Lot #: 835H, Exp 07/12
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-241-2013
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Jul 18, 2012
- FDA report date
- Apr 10, 2013
- Quantity
- 60,210 units
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Fougera Pharmaceuticals Inc.
Original FDA data
Every field from FDA enforcement report D-241-2013, exactly as published.
Show all FDA fields
- City
- Melville
- State
- NY
- Status
- Terminated
- Country
- United States
- Event ID
- 62625
- Address
- 60 Baylis Road
- Code information
- Lot #: 835H, Exp 07/12
- Postal code
- 11747-0103
- Report date
- Apr 10, 2013
- Product type
- Drugs
- Recall number
- D-241-2013
- Classification
- Class III
- Recalling firm
- Fougera Pharmaceuticals Inc.
- Product quantity
- 60,210 units
- Termination date
- Dec 10, 2015
- Reason for recall
- Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant product
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Fougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & Co., a division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-15
- Distribution pattern
- Nationwide
- Recall initiation date
- Jul 18, 2012
- Initial firm notification
- Letter
- Center classification date
- Apr 2, 2013